User profiles for S. Kalantri

SP Kalantri

Director Professor of Medicine, Mahatma Gandhi Institute of Medical Sciences, Sevagram
Verified email at mgims.ac.in
Cited by 6749

New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis

M Pai, S Kalantri, K Dheda - Expert review of molecular diagnostics, 2006 - Taylor & Francis
Nearly a third of the world’s population is estimated to be infected with Mycobacterium
tuberculosis. This enormous pool of latently infected individuals poses a major hurdle for global …

[HTML][HTML] A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis

M Morgan, S Kalantri, L Flores, M Pai - BMC infectious diseases, 2005 - Springer
… , five overlapping wild-type S probes, and four … S probes give a positive signal and all of
the R probes react negatively. RIF resistance is indicated by absence of one or more wild-type S

New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance

M Pai, S Kalantri, K Dheda - Expert review of molecular diagnostics, 2006 - Taylor & Francis
Tuberculosis (TB) is one of the world’s most important infectious causes of morbidity and
mortality among adults. Between 8 and 9 million develop TB disease, and approximately 2 …

Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon γ assay with tuberculin skin testing

M Pai, K Gokhale, R Joshi, S Dogra, S Kalantri… - Jama, 2005 - jamanetwork.com
… An estimated one third of the world’s population is infected with Mycobacterium tuberculosis,
1 presenting a major impediment to tuberculosis control. Despite the importance of latent …

Serial testing of health care workers for tuberculosis using interferon-γ assay

…, DK Mendiratta, P Narang, S Kalantri… - American journal of …, 2006 - atsjournals.org
… Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of … Pai
M, Kalantri S, Menzies D. Discordance between tuberculin skin test and interferon-γ assays […

Hydroxychloroquine prophylaxis for COVID-19 contacts in India

S Rathi, P Ish, A Kalantri, S Kalantri - The lancet infectious diseases, 2020 - thelancet.com
… 4 Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S. A systematic review on the
efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care 2020; published …

Novel tests for diagnosing tuberculous pleural effusion: what works and what does not?

…, AA Zwerling, R Joshi, S Kalantri… - European …, 2008 - Eur Respiratory Soc
Tuberculous pleuritis is a common manifestation of extrapulmonary tuberculosis and is the
most common cause of pleural effusion in many countries. Conventional diagnostic tests, …

[HTML][HTML] India's COVID-19 crisis: a call for international action

K Kuppalli, P Gala, K Cherabuddi, SP Kalantri… - The Lancet, 2021 - thelancet.com
MC has received grants paid to her institution from the US National Institute of Mental Health
(NIMH) and the South African Medical Research Council (# R01MH106600), the Fogarty …

[PDF][PDF] Nonmalarial acute undifferentiated fever in a rural hospital in central India: diagnostic uncertainty and overtreatment with antimalarial agents

…, JM Colford Jr, AL Reingold, S Kalantri - American Journal of …, 2008 - academia.edu
… We used the t test for continuous, normally distributed variables and X2 or Fisher’s exact
test as appropriate for categorical variables. All tests were two sided, with a P value of 0.05 or …

[PDF][PDF] Chikungunya epidemic: an Indian perspective

SP Kalantri, R Joshi, LW Riley - National Medical Journal of India, 2006 - researchgate.net
Chikungunya, caused by the chikungunya virus, recently emerged as an important public
health problem in the Indian Ocean islands and India In 2006, an estimated 1 38 million …